Shanmugam Muthusamy's Form 4 filing
Ani Pharmaceuticals Inc (ANIP) · filed Jun 22, 2023
- Accession no.
- 0001104659-23-073894
- Filed
- Jun 22, 2023
- Trade date
- Jun 20-22, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions. Open-market sales total $2.07M. It was filed 2 days after the trade.
This filing was later replaced by the amendment 0001104659-23-074399 (Jun 23, 2023). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Shanmugam MuthusamyCIK 0001870913 | Director, Officer (HEAD OF R&D, COO-NOVITIUM OPS) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 20, 2023 | Common Stock | SSaleDisposed | −14,657 | $51.93F2 | −$761,138.01 | 32,750 | Direct | |
| Jun 21, 2023 | Common Stock | SSaleDisposed | −11,843 | $51.95F3 | −$615,243.85 | 20,907 | Direct | |
| Jun 22, 2023 | Common Stock | SSaleDisposed | −13,500 | $51.38F4 | −$693,630 | 7,407 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $50.63 to $52.80, inclusive. The reporting person undertakes to provide to ANI Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2, 3 and 4 to this Form 4.
Referenced by the price of 1 transaction in Table I.
- F3
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $51.13 to $52.56, inclusive.
Referenced by the price of 1 transaction in Table I.
- F4
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $50.85 to $51.84, inclusive.
Referenced by the price of 1 transaction in Table I.